UK became the first country in the world to approve the Moderna updated vaccine, which targets Omicron as well as the original Omicron strains.
Britain on Monday became the first country to approve an updated Covid-19 vaccine that targets both the Omicron and original 2020 strains in what has been hailed as a significant new addition to the “Forge” against the virus.
According to a statement of the Medicines and Healthcare products Regulatory Agency (MHRA), the “bivalent” Spikevax vaccine, manufactured by Moderna, has been approved for adult booster doses “after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.”
The 25-microgram dose can be divided into two components. One targets Omicron and the other neutralizes it, MHRA said.
Covid-19 is still available in its original form. “important protection against the disease,” the regulator’s head, Dr. June Raine, said. “What this bivalent vaccine gives us is a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve,” she added.
Stephane Bancel, the CEO of Moderna, said that the US company was “Be delighted” by Britain’s decision.
“This represents the first authorization of an Omicron-containing bivalent vaccine, further highlighting the dedication and leadership of the UK public health authorities in helping to end the Covid-19 pandemic,” Bancel said in a statement.
Moderna stated that the vaccine was also submitted to approval by the Canadian, Australian, and EU authorities. Further authorization decisions are expected. “in the coming weeks.”
On August 10, 2012, 126 504,756 doses of vaccine were administered in the UK. These include 45,188.570 first doses and 42,520.292 second doses.
Share this story via social media